Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
The Lancet. Child & Adolescent Health|September 1, 2018
Life-threatening infections in children in Europe (the EUCLIDS Project): a prospective cohort studyFederico Martinón-Torres, Antonio Salas, Irene Rivero-Calle, et al.
Genes|August 27, 2021
Development and Evaluation of the Ancestry Informative Marker Panel of the VISAGE Basic ToolMaría de la Puente, Jorge Ruiz-Ramírez, Adrián Ambroa-Conde, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|May 3, 2024
Short- and mid-term morbidity and primary-care burden due to infant respiratory syncytial virus infection: A Spanish 6-year population-based longitudinal studySonia Ares-Gómez, Narmeen Mallah, Jacobo Pardo-Seco, et al.
Human Vaccines & Immunotherapeutics|May 13, 2024
Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocolNarmeen Mallah, Sonia Ares-Gómez, Jacobo Pardo-Seco, et al.
European Journal of Pediatrics|May 2, 2025
Respiratory syncytial virus-related lower respiratory tract infection hospitalizations in infants receiving nirsevimab in Galicia (Spain): the NIRSE-GAL studyAngela Manzanares, Jacobo Pardo-Seco, Irene Rivero-Calle, et al.
Vaccine|March 10, 2026
Methods and operational framework of GALFLU: Individually randomized pragmatic controlled trial of high- versus standard-dose influenza vaccination in older adultsNarmeen Mallah, Jacobo Pardo-Seco, Carmen Rodriguez-Tenreiro-Sánchez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 3, 2026
A Bayesian Re-Analysis of the GALFLU Trial of high dose versus standard dose influenza vaccine against hospitalisation outcomesJacobo Pardo-Seco, Carmen Rodriguez-Tenreiro-Sánchez, Iago Giné-Vázquez, et al.
The New England Journal of Medicine|September 1, 2025
High-Dose Influenza Vaccine to Reduce HospitalizationsJacobo Pardo-Seco, Carmen Rodríguez-Tenreiro-Sánchez, Iago Giné-Vázquez, et al.
The Lancet. Infectious Diseases|May 3, 2024
Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal studySonia Ares-Gómez, Narmeen Mallah, María-Isolina Santiago-Pérez, et al.
Circulation|November 10, 2025
High-Dose vs. Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults: The FLUNITY-HD Prespecified Pooled AnalysisNiklas Dyrby Johansen, Daniel Modin, Jacobo Pardo-Seco, et al.
Pageof 8